A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma

Am J Respir Crit Care Med. 2023 Feb 15;207(4):390-405. doi: 10.1164/rccm.202209-1729PP.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Inhalation
  • Adrenal Cortex Hormones / therapeutic use
  • Anti-Asthmatic Agents* / therapeutic use
  • Asthma* / drug therapy
  • Bronchodilator Agents / therapeutic use
  • Budesonide / therapeutic use
  • Drug Combinations
  • Ethanolamines / therapeutic use
  • Formoterol Fumarate / therapeutic use
  • Humans
  • Nebulizers and Vaporizers
  • United States

Substances

  • Formoterol Fumarate
  • Bronchodilator Agents
  • Adrenal Cortex Hormones
  • Budesonide
  • Ethanolamines
  • Drug Combinations
  • Anti-Asthmatic Agents